- testing |
| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 16 May 2025 | 9 May 2025 |
| Delhivery Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 inter alia to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31 2025. Financial Results for the Quarter and Financial Year Ended March 31, 2025 (As Per BSE Announcement Dated on: 16/05/2025) | ||
| Board Meeting | 5 Apr 2025 | 5 Apr 2025 |
| Delhivery to acquire Ecom Express Limited | ||
| Board Meeting | 7 Feb 2025 | 31 Jan 2025 |
| Delhivery Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve To consider and approve inter alia Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2024 Financial results for the quarter and nine months ended Dec 31, 2024 Appointment of Mr. Sameer Mehta as Non Executive Independent Director of the Company Appointment of Ms. Namita Thapar as Non-Executive Independent Director of the Company (As per BSE Announcement Dated on 07/02/2025) In continuation to the press release and disclosure submitted under Regulation 30 on Feb 7, 2025, we wish to clarify that inadvertently in Ms. Namita Thapars profile, it was mentioned that she is the executive Director and CEO of India Business of Emcure Pharmaceuticals Limited. Please note that she is the whole-time director of Emcure Pharmaceuticals Limited and heading its India business. (As Per BSE Announcement Dated on 08/02/2025) | ||
| Board Meeting | 14 Nov 2024 | 7 Nov 2024 |
| Delhivery Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30 2024. Financials results for the quarter and half year ended September 30, 2024 (As per BSE Announcement Dated on 14/11/2024) | ||
| Board Meeting | 2 Aug 2024 | 26 Jul 2024 |
| Delhivery Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30 2024. Financial Results Q1FY25- Unaudited Financial Results for the quarter ended June 30, 2024 (As Per BSE Announcement dated on 02.08.2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.